Attention Current Shareholders of the Chemours Company (CC)

Philadelphia, Pennsylvania--(Newsfile Corp. - March 30, 2024) - Grabar Law Office is investigating claims on behalf of shareholders of The Chemours Company (NYSE: CC). The investigation concerns whether certain officers and directors of the company have breached their fiduciary duties owed to the company.

Current Chemours shareholders who have held shares of the company's stock since at least February 10, 2023, can seek corporate reforms, the return of funds back to company coffers and potentially a court approved incentive award if appropriate, at no cost to you whatsoever. Click here to join or learn more: https://grabarlaw.com/the-latest/chemours-shareholder-investigation/

Why: According to an underlying securities fraud class action complaint, Chemours, via certain of its officers and directors, made materially false and/or misleading statements, as well as failed to disclose material adverse facts, about the Company's business and operations including that: (1) certain of the Company's senior executive officers manipulated Free Cash Flow targets as a means to maximize additional cash and stock incentive compensation applicable to executive officers pursuant to the Company's Annual Incentive Plans ("AIPs") and Long-Term Incentive Plans ("LTIPs"); (2) the Company's accounting practices and procedures, including its internal control over financial reporting, were deficient; and (3) as a result, Defendants' statements about the Company's business, operations, and prospects lacked a reasonable basis.

What to do: If you have held Chemours shares since prior to February 10, 2023 and would like to learn more at no cost to you, please visit https://grabarlaw.com/the-latest/chemours-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com or Mia Heller at mheller@grabarlaw.com, or call us at 267-507-6085.

Attorney Advertising Disclaimer

Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: 267-507-6085
Email: jgrabar@grabarlaw.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/203737